Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian Cancer

Clinical trial NCT06867562 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06867562
Sponsor: Jina Pharmaceuticals Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Platinum-Resistant Primary Peritoneal Carcinoma Platinum Resistant High Grade Epithelial Ovarian Cancer Platinum Resistant High Grade Serous Ovarian Cancer

Start date: 2025-04-01
Primary completion: 2025-12-01
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.